Automated insulin delivery systems can help pregnant women with type 1 diabetes manage their glucose during gestation.

TNDM's global expansion and strategic integrations fuel growth potential, even as pump reliance and macro pressures weigh on ...

The FDA cleared an updated algorithm for a hybrid closed-loop insulin delivery system that permits users to set a lower ...

Rosen Law Firm’s probe into Tandem Diabetes Care (TNDM) after a voluntary correction of certain t:slim X2 insulin pumps, and the roughly 20% share drop that followed, has investors reassessing risk ...

The US Food and Drug Administration (FDA) has granted clearance for the Android version of Tandem Diabetes Care’s Tandem Mobi mobile application. The app is designed to securely connect with the ...

"We're excited to bring Tandem Mobi and the best-in-class outcomes of Control-IQ+ to Android users," said John Sheridan, president and chief executive officer. "This latest integration gives Android ...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today announced that the U.S. Food and Drug Administration (FDA) has ...

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Tandem Diabetes Care, Inc. before investing. In this article, we go over a few ...

Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended September 30, 2025 and reaffirmed full ...

Achieved record third quarter sales both in the United States (U.S.) and internationally Demonstrated year-over-year and sequential gross margin improvement Progressed multi-channel initiative by: ...